Our main objective at ECS-progastrin is innovation in cancer screening and monitoring. All innovative offers of ECS-progastri ... n and its subsidiaries are based on the R&D work carried out by Dr Dominique Joubert since 2007 on the interaction between Progastrin and cancer. Progastrin is a biomarker present in the blood of patients with many different types of cancer at all stages, even early. ECS-progastrin markets the only IVD test mesuring Progastrin levels in blood. This test is an aid for doctors in the follow-up of therapies as well as in diagnosis. Now ECS-progastrin markets its test under the RUO label in the USA and CE marked elsewhere. Dear Doctors, now it's in your hands read more